Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs

Inflammopharmacology

Volumn 15, Issue 5, 2007, Pages 196-202

  Aihara, E ^a   Hayashi, S ^a   Amagase, K ^a   Kato, S ^a   Takeuchi, K ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Alendronate; Gastric ulcers; Mucosal protection; Rebamipide

Indexed keywords

ACETIC ACID; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 8; NONSTEROID ANTIINFLAMMATORY AGENT; REBAMIPIDE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BONE DISEASE; BONE REMODELING; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HEALING IMPAIRMENT; MALE; MUCOSA INFLAMMATION; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; STOMACH MUCOSA; STOMACH ULCER; ULCER HEALING;

ACETIC ACID; ADMINISTRATION, ORAL; ALANINE; ALENDRONATE; ANIMALS; ANTI-ULCER AGENTS; BLOTTING, WESTERN; DRUG INTERACTIONS; EPITHELIUM; FIBROBLAST GROWTH FACTOR 2; GASTRIC MUCOSA; MALE; MEMBRANE POTENTIALS; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; STOMACH; STOMACH ULCER;

EID: 35348960541     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-007-1592-2     Document Type: Article

References (36)

1. Amagase, K., Nishikawa, K., Aihara, E. et al. (2006) Takeuchi K. Healing impairment action of bisphosphonates on acetic acid-induced gastric ulcer in rats. Dig Dis Sci, in press.
2. Arakawa, T., Watanabe, T., Fukuda, T. et al. (1995) Rebamipide, novel prostaglandin- inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. Dig Dis Sci, 40, 2469-2472.
3. Blank, M. A., Gibson, G. W., Myers, W. R. et al. (2004) Gastric damage in the rat with nitrogen-containing bisphosphonates depends on pH. Aliment Pharmacol Ther, 14, 1215-1223.
4. Brozozowski, T., Konturek, P. C., Konturek, S. J. et al. (2001) Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and-2. Digestion, 64, 15-29.
5. Elliott, S. N., McKnight, W., Davies et al. (1998) Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci, 62, 77-91.
6. Ernst, H., Konturek, P. C., Hahn, E. G. et al. (2001) Effect of local injection with basic fibroblast growth factor (bFGF) and neutralizing antibody to bFGF on gastric ulcer healing, gastric secretion, angiogenesis and gastric blood flow. J Physiol Pharmacol, 52, 377-390.
7. Fogelman, I., Smith, L., Mazes, R. et al (1986) Absorption of oral diphosphonate in normal subjects. Clin Endocrin, 24, 57-62.
8. Geddes, A. D., D'Souza, S. M., Ebetino, F. H. et al. (1994) Structure-activity relationship and therapeutic implications. J Bone Miner Res, 8, 265-365.
9. Graham, D. Y. (2002) What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci, 47, 1665-1678.
10. Guo, J. S., Cho, C. H., Liu, E. S. et al. (2002) Antiangiogenic effect of a highly selective cyclooxygenase-2 inhibitor on gastric ulcer healing in rats. Toxicol Appl Pharmacol, 183, 41-45.
11. Hahm, K. B., Park, I. S., Kim, Y. S. et al (1997) Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells. Free Radical Biol Med, 22, 711-716.
12. Hiratsuka, T., Futagami, S., Shindo, T. et al. (2005) Rebamipide reduces indomethacin- induced gastric injury in mice via down-regulation of ICAM-1 expression. Dig Dis Sci, 50 (Suppl), S84-S89.
13. Ishihara, K., Komuro, Y., Nishiyama, N. et al, (1992) Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Arzneimittel-forschung, 42, 1462-1466.
14. Kanatsu, K., Aihara, E., Okayama, M. et al. (2004) Mucosal irritative and healing impairment action of risedronate in rat stomachs: Comparison with alendronate. J Gastroent Hapetology, 19, 512-520.
15. Kim, H., Seo, J. Y., Kim, K. H. (2000) Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells. Dig Dis Sci, 45, 621-628.
16. Kleine, A., Kluge, S., Peskar, B. M. (1993) Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci, 38, 1441-1449.
17. Laemmli, U. K. (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature, 227, 680-685.
18. Lichtenberger, L. M., Romero, J. J., Gibson, G. W. et al. (2000) Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa. Dig Dis Sci, 45, 1792-1801.
19. Lin, J. H., Duggan, D. E., Chen, I. et al. (1991) Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals. Drug Metab Dispos, 19, 297-300.
20. Luckman, S. P., Hughes, D. E., Coxon, E. P. et al. (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding protein, including rats. J Bone Miner Res, 13, 581-589.
21. Marshall, J. K., Rainsford, K. D., James, C. et al. (2000) A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract. Aliment Pharmacol Ther, 4, 1451-1457.
22. Matsumoto, J., Takeuchi, K., Ueshima, K. et al. (1992) Role of capsaicin-sensitive afferent neurons in mucosal blood flow response of rat stomach induced by mild irritants. Dig Dis Sci, 37, 1336-1344.
23. Miura, S., Tatsuguchi, A., Wada, K. et al. (2004) Cyclooxygenase-2- regulated vascular endothelial growth factor release in gastric fibroblasts. Am J Physiol, 287, G444-G451.
24. Murakami, K., Okajima, K., Harada, N. et al. (1998) Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats. Dig Dis Sc, 43, 139S-142S.
25. Okabe, S., Pfeiffer, C. J. (1972) Chronicity of acetic acid ulcer in the rat stomach. Am J Dig Dis, 17, 619-629.
26. Russell, R. G., Croucher, P. I., Roger, M. J. (1999) Bisphosphonates: Pharmacology, mechanisms of action and clinical uses. Osteoporosis Int, 9, S66-S80.
27. Sakurai, K., Osaka, T., Yamasaki, K. (2005) Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils. Dig Dis Sci, 50 (Suppl), S90-S96.
28. Suzuki, N., Takahashi, S., Okabe, S. (1998) Relationship between vascular endothelial growth factor and angiogenesis in spontaneous and indomethacin-delayed healing of acetic acid-induced gastric ulcers in rats. J Physiol Pharmacol, 49, 515-527.
29. Tarnawski, A. (2005) Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci, 50, S24-S33.
30. Tarnawski, A., Arakawa, T., Kobayashi, K. (1998) Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rat: One mechanism for its ulcer healing action? Dig Dis Sci, 43, 90S-98S.
31. Tsukimi, Y., Fujishita, K., Okabe, S. (2002) Effect of rebamipide on cell death induced by combined treatment of mild heat shock and quercetin in RGM-1 cells: Role for HSP70 induction. Pharmacology, 64, 28-35.
32. Watanabe, S., Wang, X. E., Hirose, M. et al. (1998) Rebamipide prevented delay of wound repair induced by hydrogen peroxide and suppressed apoptosis of gastric epithelial cells in vitro. Dig Dis Sci, 43 (Suppl), 107S-112S.
33. Yamasaki, K., Ishiyama, H., Imaizumi, T. et al. (1989) Effect of OPC-12795, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion. Jpn J Pharmacol, 49, 441-448.
34. Yamasaki, K., Kanbe, T.,Chijiwa, T. et al. (1987) Gastric mucosal protection by OPC-12759, a novel antiulcer compound in the rat. Eur J Pharmacol, 142, 23-29.
35. Yamasaki, K., Kane, T. (1990) Effect of rebamipide on gastric transmucosal potential difference and gastric acid back diffusion in the rat. Jpn Pharmacol Ther, 18, 147-152.
36. Yoshikawa, T., Naito, Y., Tanigawa, T. et al. (1993) Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung, 43, 363-366.